These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1187 related articles for article (PubMed ID: 1092622)

  • 1. Tumor immunology with particular reference to malignant melanoma.
    Maguire HC
    Int J Dermatol; 1975; 14(1):3-11. PubMed ID: 1092622
    [No Abstract]   [Full Text] [Related]  

  • 2. Active specific immunotherapy of minimal residual tumor: excision plus neuraminidase-treated tumor cells.
    Rios A; Simmons RL
    Int J Cancer; 1974 Jan; 13(1):71-81. PubMed ID: 4818273
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumor-protective and -facilitating antigens from 3 M KCl-solubilized tumor extracts.
    Yamagishi H; Pellis NR; Kahan BD
    J Surg Res; 1979 Apr; 26(4):392-9. PubMed ID: 431057
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuraminidase and concanavalin A in the experimental immunotherapy of cancer.
    Simmons RL; Rios A
    Johns Hopkins Med J Suppl; 1974; 3():75-84. PubMed ID: 4536589
    [No Abstract]   [Full Text] [Related]  

  • 5. Cell surface modification in the treatment of experimental cancer: neuraminidase or concanavalin A.
    Simmons RL; Rios A
    Cancer; 1974 Oct; 34(4 Suppl):suppl:1541-7. PubMed ID: 4138077
    [No Abstract]   [Full Text] [Related]  

  • 6. Tumour-associated transplantation antigens of chemically induced sarcomata cross reacting with allogeneic histocompatibility antigens.
    Invernizzi G; Parmiani G
    Nature; 1975 Apr; 254(5502):713-4. PubMed ID: 1091865
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of polyinosinic-polycytidylic acid on the immune response of mice to antigenically distinct tumors.
    Fisher JC; Cooperband SR; Mannick JA
    Cancer Res; 1972 May; 32(5):889-92. PubMed ID: 4336028
    [No Abstract]   [Full Text] [Related]  

  • 8. Horizons in tumor immunology. A seminar.
    Wilson RE; Alexander P; Rosenberg SA; Simmons RL
    Arch Surg; 1974 Jul; 109(1):17-29. PubMed ID: 4834133
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunotherapy of cancer: immunospecific rejection of tumors in recipients of neuraminidase-treated tumor cells plus BCG.
    Simmons RL; Rios A
    Science; 1971 Nov; 174(4009):591-3. PubMed ID: 4940021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attempted induction of tumor antigens in carcinogen-treated cells.
    Outzen HC; Andrews EJ; Basombrío MA; Litwin S; Prehn RT
    J Natl Cancer Inst; 1972 Nov; 49(5):1295-302. PubMed ID: 4568086
    [No Abstract]   [Full Text] [Related]  

  • 11. Antigens of chemically induced tumors.
    Della Porta G; Parmiani G
    Exp Cell Biol; 1976; 44(3-6):170-83. PubMed ID: 1029662
    [No Abstract]   [Full Text] [Related]  

  • 12. [Blood lymphocytes in cancer].
    Shats VIa
    Tsitologiia; 1972 Jan; 14(1):3-12. PubMed ID: 4551781
    [No Abstract]   [Full Text] [Related]  

  • 13. Preparation of membrane fractions with enhanced tumor-transplantation-antigen activity from tumor cells infected with influenza virus.
    Boone CW; Orme TW; Blackman K; Gillette R
    J Natl Cancer Inst; 1973 Oct; 51(4):1141-4. PubMed ID: 4355600
    [No Abstract]   [Full Text] [Related]  

  • 14. An assessment of intratumor phagocytic and surface marker-bearing cells in a series of autochthonous and early passaged chemically induced murine sarcomas.
    Pross HF; Kerbel RS
    J Natl Cancer Inst; 1976 Nov; 57(5):1157-67. PubMed ID: 1087351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of antigenicity of melanoma cells grown in 5-bromodeoxyuridine to reduced tumorigenicity.
    Silagi S; Newcomb EW; Weksler ME
    Cancer Res; 1974 Jan; 34(1):100-4. PubMed ID: 4358536
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of immunology in human cancer research.
    Gold P
    Can Med Assoc J; 1970 Nov; 103(10):1043-51. PubMed ID: 4924389
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuraminidase treated cells and their role in cancer immunotherapy.
    Simmons RL; Rios A
    Birth Defects Orig Artic Ser; 1973 Mar; 9(2):223-8. PubMed ID: 4611534
    [No Abstract]   [Full Text] [Related]  

  • 18. Tumor-specific antigens and reexpression of fetal antigens in mammalian cells.
    Lausch RN; Rapp F
    Prog Exp Tumor Res; 1974; 19():45-58. PubMed ID: 4373784
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro demonstration of cryosurgical augmentation of tumor immunity.
    Faraci RP; Bagley DH; Marrone J; Beazley RM
    Surgery; 1975 Mar; 77(3):433-8. PubMed ID: 1124499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Separation of the tumor-associated transplantation antigen (TATA) from the alien H-2k antigens expressed on a methylcholanthrene-induced tumor.
    Rogers MJ; Law LW; Pierotti MA; Parmiani G
    Int J Cancer; 1980 Jan; 25(1):105-9. PubMed ID: 7399738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.